Objective To prospectively monitor changes iodine-water concertration with enhanced spectral CT imaging in lung cancer and to evaluate whether iodine-water concertrations correlate with response to chemotherapy. Methods Sixteen patients with lung cancer, confirmed by histopathology and underwent chemotherapy, were enrolled in this study. Enhanced spectral CT imaging with a standard injection protocol was repeated with fast kVp switching technique at 80 and 140 kVp in pre-chemotherapy and post-chemotherapy. We measured iodine-water concertrations (IC) of each lesion in pre-chemotherapy and post-chemotherapy in plain and venous phase respectively. Using the RECIST criteria of complete response (CR), partial response (PR), stable disease (SD), and progressive disease (PD), we evaluated the patients' tumor responses after 3 months by CT scans. Results After chemotherapy, five cases had PR, nine cases had SD and two cases had PD. The difference of CT values in pre-chemotherapy and post-chemotherapy for PR , SD and PD group were 14.41 ± 10.67, 1.49 ± 11.95 and-16.08 ± 12.58, while the difference of iodine content (IC) values were 0.098 ± 0.69, 0.28 ± 0.35 and -0.146 ± 0.86 respectively. The difference of CT values in pre-chemotherapy and post-chemotherapy for PR , SD and PD group were 17.41 ± 9.83, 5.48 ± 7.55 and -10.66 ± 8.42 in venous phase , while the difference of iodine content (IC) values were 1.24 ± 0.56, 0.87 ± 0.16 and -1.45 ± 0.44 respectively. Significant correlation was seen between changes in CT vlaue, iodine content (IC) value and tumor response to therapy in plain and venous phase (r = -0.23, P = 0.036; r = -0.60, P = 0.014; r = -0.69, P = 0. 025; r = -0.71, P = 0. 007; respectively). Conclusions Iodine-water concertrations with spectral CT imaging could be useful to assessing the response of lung cancer to chemotherapy. A combination of the RECIST criteria and iodine content change in gemstone spectral imaging are proposed for response evaluation in lung cancer.